These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 6102458)
1. Phenothiazine levels in plasma and red blood cells. Their relationship to clinical improvement in schizophrenia. Casper R; Garver DL; Dekirmenjian H; Chang S; Davis JM Arch Gen Psychiatry; 1980 Mar; 37(3):301-5. PubMed ID: 6102458 [TBL] [Abstract][Full Text] [Related]
2. Neuroleptic drug levels and therapeutic response: preliminary observations with red blood cell bound butaperazine. Garver DL; Dekirmenjian H; Davis JM; Casper R; Ericksen S Am J Psychiatry; 1977 Mar; 134(3):304-7. PubMed ID: 14514 [TBL] [Abstract][Full Text] [Related]
3. Relationship of butaperazine blood levels to plasma prolactin in chronic schizophrenic patients. Smith RC; Tamminga CA; Crayton JW; Dekirmenjian H; Davis JM Psychopharmacology (Berl); 1979; 66(1):29-33. PubMed ID: 44374 [TBL] [Abstract][Full Text] [Related]
4. Blood levels of neuroleptic drugs in nonresponding chronic schizophrenic patients. Smith RC; Crayton J; Dekirmenjian H; Klass D; Davis JM Arch Gen Psychiatry; 1979 May; 36(5):579-84. PubMed ID: 35115 [TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of red blood cell phenothiazine and clinical effects. Acute dystonic reactions. Garver DL; Davis JM; Dekirmenjian H; Jones FD; Casper R; Haraszti J Arch Gen Psychiatry; 1976 Jul; 33(7):862-6. PubMed ID: 8025 [TBL] [Abstract][Full Text] [Related]
6. Plasma and red cell levels of thioridazine and clinical response in schizophrenia. Smith RC; Baumgartner R; Ravichandran GK; Shvartsburd A; Schoolar JC; Allen P; Johnson R Psychiatry Res; 1984 Aug; 12(4):287-96. PubMed ID: 6594712 [TBL] [Abstract][Full Text] [Related]
7. Determination of butaperazine in biological fluids by gas chromatography using nitrogen specific detection system. Javaid JI; Dekirmenjian H; Liskevych U; Davis JM J Chromatogr Sci; 1979 Dec; 17(12):666-70. PubMed ID: 43334 [TBL] [Abstract][Full Text] [Related]
8. RBC and plasma levels of haloperidol and clinical response in schizophrenia. Smith RC; Vroulis G; Shvartsburd A; Allen R; Lewis N; Schoolar JC; Chojnacki M; Johnson R Am J Psychiatry; 1982 Aug; 139(8):1054-6. PubMed ID: 7091432 [TBL] [Abstract][Full Text] [Related]
9. Blood levels of neuroleptics: state of the art. Simpson GM; Yadalam K J Clin Psychiatry; 1985 May; 46(5 Pt 2):22-8. PubMed ID: 2859277 [TBL] [Abstract][Full Text] [Related]
11. Therapeutic drug monitoring for optimizing amisulpride therapy in patients with schizophrenia. Müller MJ; Regenbogen B; Härtter S; Eich FX; Hiemke C J Psychiatr Res; 2007 Oct; 41(8):673-9. PubMed ID: 16324716 [TBL] [Abstract][Full Text] [Related]
12. The relationship between blood levels of different forms of butaperazine and clinical response. Simpson GM; Lament R; Cooper TB; Lee JH; Bruce RB J Clin Pharmacol; 1973 Jul; 13(7):288-97. PubMed ID: 4145866 [No Abstract] [Full Text] [Related]
13. The relationship between plasma and red blood cell neuroleptic levels, oral dosage, and clinical parameters in a chronic schizophrenic population. Dunlop SR; Shea PA; Hendrie HC Biol Psychiatry; 1982 Aug; 17(8):929-36. PubMed ID: 6126231 [TBL] [Abstract][Full Text] [Related]
14. Relation of plasma prolactin to clinical response in schizophrenic patients. Gruen PG; Sachar EJ; Altman N; Langer G; Tabrizi MA; Halpern FS Arch Gen Psychiatry; 1978 Oct; 35(10):1222-7. PubMed ID: 29592 [TBL] [Abstract][Full Text] [Related]